{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"heparin-induced-thrombocytopenia","columns":[{"gene":"","key":"population-ea6485b23ab1b031323a","label":"Classic heparin-induced thrombocytopenia","mondoId":"MONDO:0018048","onsetQualifier":null,"originColumnKey":"MONDO:0018048/ORPHA:3325","originalViews":[{"key":"MONDO:0018048/ORPHA:3325","label":"Classic heparin-induced thrombocytopenia","scopeLabel":"ORPHA:3325","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["039270cce3cccc83be9f667729b428e9c34e3ca94f908308687a0d143d5d935e","07c7696519ae97bfe8b1cc6fb32222bcb72faeaaaa1c0504ceb2f2e53459b82d","61194ab8d4d7221d7c3b76e719d8d2435dbbd7170a7cbd2b8fe52c4e4476efb2","6a3573bdfbd06b5fe516994f9615c8b008898612a751484cb8a8cc9382e3cff6","6e2006b51958fb2aeb2bb93260d748d1dc78e82e065b0ba195bc3cd63f28a6be","7194c2c3f4798ad0c7d202d3ae9439d4ef278296d23ba17f951f5145c2483bc1","7d17898224b4876f712f548c51d910e6fc4495eccd0ffae7891829a26c005047","ad8838e5a9c846c7c4543d65f4393a70a729781cefc7adc73b96642a0ebf84d8","b59116460c6404528f6c0901b43a274b845c99b121801af5b23cc813dac237c4","bd2f86b6947c3ba02c3dcbc1f2c7f896a1db169a35ff53d84ebddf5f1a8c10a6","be395b5eaa0c1bce17a130838b07a68603ed5f3d8a4278f0c2e20368bfe43576","dbbceae28f74877b91765bc414b707993c7c5ead46ce5d3b34e12ba3f94744f6","e568619aab5af38827ec405b8a5bd9fc9ad2a140873d11832352afffe90409e7","e5f2faa12402c5002be4a7330866a5ed503120d5f444ae6424458512eab6900a","f992302635351fd0bdb5e12855c2814fa221335b2e1ae07404678a739ce1472b"],"recordQualifiers":{},"scopeLabel":"ORPHA:3325","sourceIds":["ORPHA:3325"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-ea6485b23ab1b031323a"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0040231","HP:0004420","HP:0001973","HP:0002637","HP:0002625","HP:0005521","HP:0100724"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":15,"sourceGroups":{"orphanet":15}},"features":[{"hpoId":"HP:0040231","label":"Abnormal onset of bleeding","primary":true},{"hpoId":"HP:0004420","label":"Arterial thrombosis","primary":true},{"hpoId":"HP:0001973","label":"Autoimmune thrombocytopenia","primary":true},{"hpoId":"HP:0002637","label":"Cerebral ischemia","primary":true},{"hpoId":"HP:0002625","label":"Deep venous thrombosis","primary":true},{"hpoId":"HP:0005521","label":"Disseminated intravascular coagulation","primary":true},{"hpoId":"HP:0100724","label":"Hypercoagulability","primary":true},{"hpoId":"HP:0012649","label":"Increased inflammatory response","primary":false},{"hpoId":"HP:0003144","label":"Increased serum serotonin","primary":false},{"hpoId":"HP:0030248","label":"Mesenteric venous thrombosis","primary":false},{"hpoId":"HP:0001658","label":"Myocardial infarction","primary":false},{"hpoId":"HP:0002204","label":"Pulmonary embolism","primary":false},{"hpoId":"HP:0001297","label":"Stroke","primary":false},{"hpoId":"HP:0001907","label":"Thromboembolism","primary":false},{"hpoId":"HP:0004936","label":"Venous thrombosis","primary":false}],"ledeHtml":"Heparin-induced thrombocytopenia (HIT) is an adverse reaction to the drug heparin resulting in an abnormally low amount of platelets (thrombocytopenia). HIT is usually an immune response which typically occurs 4-10 days after exposure to heparin. It can lead to serious complications. This condition occurs in up to 5% of those who are exposed to heparin. Characteristic signs of HIT are a drop in platelet count of greater than 50% and/or the formation of new blood clots during heparin therapy.","mondoId":"MONDO:0018048","node":{"canonicalSlug":"heparin-induced-thrombocytopenia","comparisons":[{"documentSha256":"faec3cd1ad23db40dc472422b706d3189cad340d92dce3e53d82c43bdd640e47","key":"legacy-heparin-induced-thrombocytopenia","kind":"legacy","label":"heparin-induced thrombocytopenia","memberIds":["MONDO:0018048"],"mondoId":"MONDO:0018048","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/heparin-induced-thrombocytopenia.faec3cd1ad23db40dc472422b706d3189cad340d92dce3e53d82c43bdd640e47.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Heparin-induced thrombocytopenia","originalSourceId":"ORPHA:3325","paragraphs":["Heparin-induced thrombocytopenia (HIT) is an adverse reaction to the drug heparin resulting in an abnormally low amount of platelets (thrombocytopenia). HIT is usually an immune response which typically occurs 4-10 days after exposure to heparin. It can lead to serious complications. This condition occurs in up to 5% of those who are exposed to heparin. Characteristic signs of HIT are a drop in platelet count of greater than 50% and/or the formation of new blood clots during heparin therapy."],"rawAttribution":"MONDO:0018048","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:04:09Z","upstream":"GARD:0002650","url":"https://rarediseases.info.nih.gov/diseases/2650"},"ownColumnKeys":["population-ea6485b23ab1b031323a"],"publication":"published","relationships":[{"kind":"parent","label":"thrombotic disease","mondoId":"MONDO:0000831","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"039270cce3cccc83be9f667729b428e9c34e3ca94f908308687a0d143d5d935e","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:3325","disease_name":"Classic heparin-induced thrombocytopenia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001658","is_excluded":false,"label":"Myocardial infarction","onset_id":null,"reference":"ORPHA:3325","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"07c7696519ae97bfe8b1cc6fb32222bcb72faeaaaa1c0504ceb2f2e53459b82d","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:3325","disease_name":"Classic heparin-induced thrombocytopenia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003144","is_excluded":false,"label":"Increased serum serotonin","onset_id":null,"reference":"ORPHA:3325","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"61194ab8d4d7221d7c3b76e719d8d2435dbbd7170a7cbd2b8fe52c4e4476efb2","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:3325","disease_name":"Classic heparin-induced thrombocytopenia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012649","is_excluded":false,"label":"Increased inflammatory response","onset_id":null,"reference":"ORPHA:3325","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6a3573bdfbd06b5fe516994f9615c8b008898612a751484cb8a8cc9382e3cff6","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:3325","disease_name":"Classic heparin-induced thrombocytopenia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002637","is_excluded":false,"label":"Cerebral ischemia","onset_id":null,"reference":"ORPHA:3325","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6e2006b51958fb2aeb2bb93260d748d1dc78e82e065b0ba195bc3cd63f28a6be","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:3325","disease_name":"Classic heparin-induced thrombocytopenia","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0040231","is_excluded":false,"label":"Abnormal onset of bleeding","onset_id":null,"reference":"ORPHA:3325","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7194c2c3f4798ad0c7d202d3ae9439d4ef278296d23ba17f951f5145c2483bc1","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:3325","disease_name":"Classic heparin-induced thrombocytopenia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001907","is_excluded":false,"label":"Thromboembolism","onset_id":null,"reference":"ORPHA:3325","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7d17898224b4876f712f548c51d910e6fc4495eccd0ffae7891829a26c005047","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:3325","disease_name":"Classic heparin-induced thrombocytopenia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004420","is_excluded":false,"label":"Arterial thrombosis","onset_id":null,"reference":"ORPHA:3325","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ad8838e5a9c846c7c4543d65f4393a70a729781cefc7adc73b96642a0ebf84d8","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:3325","disease_name":"Classic heparin-induced thrombocytopenia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002204","is_excluded":false,"label":"Pulmonary embolism","onset_id":null,"reference":"ORPHA:3325","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b59116460c6404528f6c0901b43a274b845c99b121801af5b23cc813dac237c4","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:3325","disease_name":"Classic heparin-induced thrombocytopenia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0005521","is_excluded":false,"label":"Disseminated intravascular coagulation","onset_id":null,"reference":"ORPHA:3325","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bd2f86b6947c3ba02c3dcbc1f2c7f896a1db169a35ff53d84ebddf5f1a8c10a6","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:3325","disease_name":"Classic heparin-induced thrombocytopenia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002625","is_excluded":false,"label":"Deep venous thrombosis","onset_id":null,"reference":"ORPHA:3325","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"be395b5eaa0c1bce17a130838b07a68603ed5f3d8a4278f0c2e20368bfe43576","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:3325","disease_name":"Classic heparin-induced thrombocytopenia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001973","is_excluded":false,"label":"Autoimmune thrombocytopenia","onset_id":null,"reference":"ORPHA:3325","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dbbceae28f74877b91765bc414b707993c7c5ead46ce5d3b34e12ba3f94744f6","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:3325","disease_name":"Classic heparin-induced thrombocytopenia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001297","is_excluded":false,"label":"Stroke","onset_id":null,"reference":"ORPHA:3325","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e568619aab5af38827ec405b8a5bd9fc9ad2a140873d11832352afffe90409e7","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:3325","disease_name":"Classic heparin-induced thrombocytopenia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030248","is_excluded":false,"label":"Mesenteric venous thrombosis","onset_id":null,"reference":"ORPHA:3325","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e5f2faa12402c5002be4a7330866a5ed503120d5f444ae6424458512eab6900a","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:3325","disease_name":"Classic heparin-induced thrombocytopenia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004936","is_excluded":false,"label":"Venous thrombosis","onset_id":null,"reference":"ORPHA:3325","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f992302635351fd0bdb5e12855c2814fa221335b2e1ae07404678a739ce1472b","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:3325","disease_name":"Classic heparin-induced thrombocytopenia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0100724","is_excluded":false,"label":"Hypercoagulability","onset_id":null,"reference":"ORPHA:3325","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/2650\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018048\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0002650</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Heparin-induced thrombocytopenia (HIT) is an adverse reaction to the drug heparin resulting in an abnormally low amount of platelets (thrombocytopenia). HIT is usually an immune response which typically occurs 4-10 days after exposure to heparin. It can lead to serious complications. This condition occurs in up to 5% of those who are exposed to heparin. Characteristic signs of HIT are a drop in platelet count of greater than 50% and/or the formation of new blood clots during heparin therapy.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/2650\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"heparin-induced-thrombocytopenia","sourceDocuments":[{"name":"GARD: Heparin-induced thrombocytopenia","reviewed":null,"source_release":"2026-10-21T17:04:09Z","url":"https://rarediseases.info.nih.gov/diseases/2650"},{"name":"MONDO: heparin-induced thrombocytopenia","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0018048"}],"sourceNote":"","synonyms":["HAT","heparin-associated thrombocytopenia","heparin-induced thrombocytopenia","heparin-induced thrombocytopenia (disease)","heparin-induced thrombocytopenia type 2","HIT"],"takeawayHtml":"","title":"heparin-induced thrombocytopenia"},"schemaVersion":1}
